Pharma Journalist 9001 posts 0 comments

AC Immune SA has strengthened its long-standing partnership with Eli Lilly and Company through an amendment to their 2018 collaboration agreement, advancing efforts to develop novel…
Read More...

Nxera Pharma Co., Ltd. has reached a key development milestone in its ongoing collaboration with Eli Lilly and Company, advancing joint efforts to develop new treatments for diabetes…
Read More...

Sidewinder Therapeutics has raised $137 million in an oversubscribed Series B financing round, signaling strong investor confidence in its next-generation cancer treatment platform…
Read More...

Jeito Capital has successfully closed its second fund, Jeito II, raising $1.2 billion and exceeding its initial target, in a move that underscores growing investor confidence in…
Read More...

Join the 3rd Biophysics for Drug Discovery Summit – The Countdown Is On! Biophysical methods underpin some of today’s most powerful drug discovery decisions — yet translating physical…
Read More...

Join the 5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit As lipid-based therapeutics continue to advance, developers face growing pressure to deliver precise,…
Read More...

Ahead of the Investigative & Preclinical Toxicology Summit 2026, the dedicated Pre‑Conference Workshop Day is emerging as one of the most highly anticipated elements of the meeting,…
Read More...

RoosterBio, Inc. has entered into an exclusive distribution agreement with MineBio Life Sciences Limited to expand access to advanced cell therapy manufacturing solutions across China,…
Read More...

Gilead Sciences, Inc. has announced a definitive agreement to acquire Tubulis GmbH, a clinical-stage biotech firm specializing in next-generation antibody-drug conjugates (ADCs). The…
Read More...

Halozyme Therapeutics, Inc. has announced a new global collaboration and licensing agreement with Vertex Pharmaceuticals Incorporated aimed at advancing innovative drug delivery…
Read More...